DCGI approves export of SII-made Ebola vax to Uganda for clinical trials

Daily Current Affairs / DCGI approves export of SII-made Ebola vax to Uganda for clinical trials

Change Language English Hindi

Category : International Published on: December 12 2022

Share on facebook

The Drugs Controller General of India (DCGI) has approved Ebola vaccine manufactured by the Serum Institute for export to Uganda. This is the first ebola vaccine made in India.
The vaccine has been developed by the Pune-based pharma firm in collaboration with Oxford University, UK.
The World Health Organisation (WHO) had sought collaboration with manufacturers of ebola vaccines for the prevention of the disease and has selected ChAdOx1 biEBOV as a potential vaccine for participation in a solidarity clinical trial in Uganda.
Oxford University signed an agreement with Serum Institute of India to manufacture ChAdOx1 biEBOV.

Aernnova Aerospace signs a $300 million contract with Mahindra Aerostructures to manufacture aircraft components for Airbus and Embraer.
Read More....
Smriti Mandhana regains No.1 spot in ICC ODI batting rankings after six years.
Read More....
Hindustan Zinc to invest ₹12,000 crore to set up a new integrated zinc smelter in Rajasthan.
Read More....
Indian Army contingent departs for 8th India-France joint military exercise SHAKTI in France.
Read More....
U Mumba wins their first-ever Ultimate Table Tennis title with an 8-4 victory over Jaipur Patriots.
Read More....
Indian boxer Nishant Dev wins his second professional fight at Madison Square Garden, New York.
Read More....
CCI approves Delhivery’s acquisition of 99.44% stake in Ecom Express.
Read More....
Ministry of Panchayati Raj to sign MoU with Bhashini to improve multilingual e-Governance.
Read More....
Fast-food chain Dairy Queen, owned by Warren Buffett, to enter Indian market via Devyani International.
Read More....
Tom Cruise, Dolly Parton, Debbie Allen, and Wynn Thomas to receive honorary Oscars in 2025.
Read More....

DCGI approves export of SII-made Ebola vax to Uganda for clinical trials